We want to congratulate three graduate students from our group who were recently awarded training grants from the Fondation du CHU de Québec – Université Laval of $5,000 each. These students are Claudia Beaudoin, a PhD student in epidemiology under the supervision of Dr. Lynne Moore, as well as Jihad Abou Jamous and Michael Verret, MSc students in clinical epidemiology under the supervision of Dr. Alexis Turgeon.
We are happy to announce that Marie-Pier Patton, MSc student under the supervision of Dr. Lynne Moore, was awarded a travel award to participate in the scientific meeting of the Canadian Traumatic Brain Injury Research Consortium (CTRC), which was held in Lake Louise (AB), from January 24th to the 26th 2018.
Michael Verret, anesthesiology resident and MSc candidate in clinical epidemiology under the supervision of Dr. Alexis Turgeon, was awarded the Desjardins Scholarship for his “perseverance and scientific determination” worth $3,000.
Recruitment for the HEMOTION Trial is progressing well at the CHU de Québec-University Laval. We are looking forward to starting this new trial with the other Canadian and UK sites.
The HEMOTION Trial Start-up Meeting was held in Lake Louise, on January 22, 2018. Site investigators and research coordinators from the Canadian participating sites attended the meeting. Drs. Alexis Turgeon, Dean Fergusson and François Lauzier are the principal investigators of this multicenter randomized controlled trial aimed at establishing the optimal transfusion strategy in patients with moderate to severe traumatic brain injury.
The winter meeting of the Canadian Critical Care Trials Group (CCCTG) was held from January 22nd to the 25th followed by the Canadian Traumatic brain injury Research Consortium (CTRC) held on January 25th and 26th. The first morning session of the CTRC was held jointly with the CCCTG. These two collaborative research networks aim at promoting, developing and consolidating collaborations between researchers accross Canada in the fields of critical care medicine and TBI, respectively.